Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WA9U
|
|||
| Drug Name |
PMID29649907-Compound-1
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
INTERCEPT PHARMACEUTICALS, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H44O4
|
|||
| Canonical SMILES |
CCC1C2CCCCC2(C3C(CC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)O)C
|
|||
| InChI |
1S/C26H44O4/c1-5-16-18-8-6-7-13-25(18,3)23-20(27)14-26(4)17(15(2)9-12-21(28)29)10-11-19(26)22(23)24(16)30/h15-20,22-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18+,19?,20+,22?,23?,24-,25+,26-/m1/s1
|
|||
| InChIKey |
IMDDBKRWRHUMNT-QAUCXMOESA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Farnesoid X-activated receptor (FXR) | Target Info | Agonist | [1] |
| Target's Patent Info | Farnesoid X-activated receptor (FXR) | Target's Patent Info | [1] | |
| KEGG Pathway | Bile secretion | |||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
| Reactome | Recycling of bile acids and salts | |||
| PPARA activates gene expression | ||||
| Endogenous sterols | ||||
| WikiPathways | Nuclear Receptors in Lipid Metabolism and Toxicity | |||
| Nuclear Receptors Meta-Pathway | ||||
| Farnesoid X Receptor Pathway | ||||
| Drug Induction of Bile Acid Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Farnesoid X receptor modulators 2014-present: a patent review.Expert Opin Ther Pat. 2018 May;28(5):351-364. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.